These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2128445)

  • 21. Treatment of hyperstimulation during in-vitro fertilization.
    Salat-Baroux J; Alvarez S; Antoine JM; Cornet D; Tibi C; Plachot M; Mandelbaum J
    Hum Reprod; 1990 Jan; 5(1):36-9. PubMed ID: 2108982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin and estradiol levels during ovarian stimulation in women treated with leuprolide acetate.
    Stone BA; Serafini PC; Quinn K; Quinn P; Kerin JF; Marrs RP
    Obstet Gynecol; 1989 Jun; 73(6):990-5. PubMed ID: 2498795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
    Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
    Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
    Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
    Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.
    Matsumoto K; Imakawa K; Hayashi C
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):312. PubMed ID: 28931393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different follicle-stimulating hormone and luteinizing hormone ratios for ovulation induction during in vitro fertilization.
    Tepper R; Tadir Y; Kaplan-Kraicer R; Amit S; Pinkas H; Ovadia J
    Int J Fertil; 1992; 37(6):335-8. PubMed ID: 1360452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormonal therapy for the synchronization between donor and recipient in an oocyte donation and surrogacy fertilization in vitro-embryo transfer program].
    Zhang L; Chen G; Liu P
    Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):486-9. PubMed ID: 9275443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of purified gonadotrophins for ovarian stimulation in IVF.
    Jones GS
    Clin Obstet Gynaecol; 1985 Dec; 12(4):775-84. PubMed ID: 3938687
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge.
    Eibschitz I; Belaisch-Allart JC; Frydman R
    Fertil Steril; 1986 Feb; 45(2):231-6. PubMed ID: 3081376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
    Tang PL; Chan TY; Tang GW; Pang SF
    Gynecol Obstet Invest; 1998; 45(4):247-52. PubMed ID: 9623790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women.
    Abuzeid MI; Hodges JK; Harlow CR; Hull MG
    J Assist Reprod Genet; 1996 Sep; 13(8):629-34. PubMed ID: 8897122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.